(RJF) Raymond James Financial - Overview
Stock: Private Client Group, Capital Markets, Asset Management, Bank, Other
EPS (Earnings per Share)
Revenue
Dividends
| Dividend Yield | 1.31% |
| Yield on Cost 5y | 3.00% |
| Yield CAGR 5y | 8.75% |
| Payout Consistency | 89.6% |
| Payout Ratio | 15.1% |
| Risk 5d forecast | |
|---|---|
| Volatility | 23.4% |
| Relative Tail Risk | -1.44% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.03 |
| Alpha | -15.93 |
| Character TTM | |
|---|---|
| Beta | 0.997 |
| Beta Downside | 1.063 |
| Drawdowns 3y | |
|---|---|
| Max DD | 28.12% |
| CAGR/Max DD | 0.54 |
Description: RJF Raymond James Financial January 29, 2026
Raymond James Financial Inc. (NYSE:RJF) is a diversified financial-services firm operating four core segments: Private Client Group (wealth-management and brokerage services), Capital Markets (investment banking and institutional brokerage), Asset Management (retail and institutional portfolio management), and a Bank (loans, deposits, and liquidity products). The company also holds a modest “Other” segment for private-equity fund investments. Headquartered in Saint Petersburg, Florida, RJF serves individuals, corporations, and municipalities across the United States, Canada, and Europe.
In its most recent quarter (Q2 2025), RJF reported revenue of $1.65 billion, up 5 % year-over-year, driven primarily by a 9 % increase in Private Client Group net interest income and a 4 % rise in Capital Markets brokerage fees. Assets under management reached $380 billion, while the bank’s loan portfolio expanded 8 % YoY to $31 billion, supporting a net interest margin of 2.9 %. The firm’s earnings per share were $6.85, and its operating margin held steady at 16 %, reflecting resilience amid a higher-for-longer interest-rate environment that benefits loan earnings but compresses brokerage commissions as market volatility eases.
For a deeper dive into RJF’s valuation nuances, explore the analyst toolkit on ValueRay.
Piotroski VR‑10 (Strict, 0-10) 5.0
| Net Income: 2.10b TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.02 > 0.02 and ΔFCF/TA -1.09 > 1.0 |
| NWC/Revenue: -282.5% < 20% (prev -268.9%; Δ -13.59% < -1%) |
| CFO/TA 0.02 > 3% & CFO 1.60b > Net Income 2.10b |
| Net Debt (-6.84b) to EBITDA (2.84b): -2.41 < 3 |
| Current Ratio: 0.32 > 1.5 & < 3 |
| Outstanding Shares: last quarter (201.4m) vs 12m ago -3.73% < -2% |
| Gross Margin: 88.50% > 18% (prev 0.86%; Δ 8764 % > 0.5%) |
| Asset Turnover: 18.57% > 50% (prev 18.53%; Δ 0.04% > 0%) |
| Interest Coverage Ratio: 1.10 > 6 (EBITDA TTM 2.84b / Interest Expense TTM 1.79b) |
Altman Z'' -2.48
| A: -0.51 (Total Current Assets 21.10b - Total Current Liabilities 65.97b) / Total Assets 88.80b |
| B: 0.15 (Retained Earnings 13.60b / Total Assets 88.80b) |
| C: 0.02 (EBIT TTM 1.97b / Avg Total Assets 85.54b) |
| D: 0.17 (Book Value of Equity 13.21b / Total Liabilities 76.31b) |
| Altman-Z'' Score: -2.48 = D |
Beneish M -2.93
| DSRI: 1.07 (Receivables 4.63b/4.16b, Revenue 15.88b/15.24b) |
| GMI: 0.97 (GM 88.50% / 86.05%) |
| AQI: 1.04 (AQ_t 0.75 / AQ_t-1 0.72) |
| SGI: 1.04 (Revenue 15.88b / 15.24b) |
| TATA: 0.01 (NI 2.10b - CFO 1.60b) / TA 88.80b) |
| Beneish M-Score: -2.93 (Cap -4..+1) = A |
What is the price of RJF shares?
Over the past week, the price has changed by -1.67%, over one month by -0.68%, over three months by +4.96% and over the past year by +1.46%.
Is RJF a buy, sell or hold?
- StrongBuy: 2
- Buy: 2
- Hold: 10
- Sell: 0
- StrongSell: 0
What are the forecasts/targets for the RJF price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 184.8 | 11.2% |
| Analysts Target Price | 184.8 | 11.2% |
| ValueRay Target Price | 187 | 12.5% |
RJF Fundamental Data Overview February 01, 2026
P/E Forward = 13.9276
P/S = 2.2984
P/B = 2.614
P/EG = 1.355
Revenue TTM = 15.88b USD
EBIT TTM = 1.97b USD
EBITDA TTM = 2.84b USD
Long Term Debt = 4.22b USD (from longTermDebt, last fiscal year)
Short Term Debt = 325.0m USD (from shortTermDebt, last fiscal year)
Debt = 4.54b USD (from shortLongTermDebtTotal, last fiscal year)
Net Debt = -6.84b USD (from netDebt column, last fiscal year)
Enterprise Value = 25.83b USD (32.67b + Debt 4.54b - CCE 11.39b)
Interest Coverage Ratio = 1.10 (Ebit TTM 1.97b / Interest Expense TTM 1.79b)
EV/FCF = 17.73x (Enterprise Value 25.83b / FCF TTM 1.46b)
FCF Yield = 5.64% (FCF TTM 1.46b / Enterprise Value 25.83b)
FCF Margin = 9.17% (FCF TTM 1.46b / Revenue TTM 15.88b)
Net Margin = 13.21% (Net Income TTM 2.10b / Revenue TTM 15.88b)
Gross Margin = 88.50% ((Revenue TTM 15.88b - Cost of Revenue TTM 1.83b) / Revenue TTM)
Gross Margin QoQ = 89.44% (prev 88.64%)
Tobins Q-Ratio = 0.29 (Enterprise Value 25.83b / Total Assets 88.80b)
Interest Expense / Debt = 9.70% (Interest Expense 441.0m / Debt 4.54b)
Taxrate = 22.66% (165.0m / 728.0m)
NOPAT = 1.52b (EBIT 1.97b * (1 - 22.66%))
Current Ratio = 0.32 (Total Current Assets 21.10b / Total Current Liabilities 65.97b)
Debt / Equity = 0.36 (Debt 4.54b / totalStockholderEquity, last quarter 12.49b)
Debt / EBITDA = -2.41 (Net Debt -6.84b / EBITDA 2.84b)
Debt / FCF = -4.70 (Net Debt -6.84b / FCF TTM 1.46b)
Total Stockholder Equity = 12.37b (last 4 quarters mean from totalStockholderEquity)
RoA = 2.45% (Net Income 2.10b / Total Assets 88.80b)
RoE = 16.97% (Net Income TTM 2.10b / Total Stockholder Equity 12.37b)
RoCE = 11.85% (EBIT 1.97b / Capital Employed (Equity 12.37b + L.T.Debt 4.22b))
RoIC = 9.75% (NOPAT 1.52b / Invested Capital 15.58b)
WACC = 9.34% (E(32.67b)/V(37.22b) * Re(9.59%) + D(4.54b)/V(37.22b) * Rd(9.70%) * (1-Tc(0.23)))
Discount Rate = 9.59% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -100.0 | Cagr: -2.94%
[DCF Debug] Terminal Value 64.42% ; FCFF base≈1.77b ; Y1≈1.16b ; Y5≈530.9m
Fair Price DCF = 77.55 (EV 8.43b - Net Debt -6.84b = Equity 15.28b / Shares 197.0m; r=9.34% [WACC]; 5y FCF grow -40.0% → 2.90% )
[DCF Warning] FCF declining rapidly (-40.0%), DCF may be unreliable
EPS Correlation: 81.12 | EPS CAGR: 17.75% | SUE: -0.39 | # QB: 0
Revenue Correlation: 96.57 | Revenue CAGR: 12.21% | SUE: 0.54 | # QB: 0
EPS next Quarter (2026-03-31): EPS=2.90 | Chg30d=+0.001 | Revisions Net=+2 | Analysts=11
EPS current Year (2026-09-30): EPS=12.07 | Chg30d=+0.075 | Revisions Net=-2 | Growth EPS=+13.2% | Growth Revenue=+10.9%
EPS next Year (2027-09-30): EPS=13.72 | Chg30d=+0.250 | Revisions Net=+3 | Growth EPS=+13.7% | Growth Revenue=+7.7%